Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...
Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a breakthrough Continuous ...
So, here are some ways to reduce your risk of dementia: “Research suggests that social isolation is linked to an increased ...
"Detect the SOS is a multi-stakeholder movement that brings together trusted voices, advocates, healthcare professionals and ...
Learn how to manage blood sugar during meals with these tips, such as starting with veggies, saving carbs for last, staying ...
Studies indicate that the number of dementia cases in the United States is expected to double by 2060. A new study published ...
Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. -ASC30 ...
Meet two teen entrepreneurs making a difference and learn why corporations should pay attention to their ideas and impact.
The pilot program allows an AI system to renew a limited list of routine medications for patients without requiring an ...
Merck Foundation Chief Executive Officer (CEO) and Zimbabwe First Lady discussed the impact of their programs - Train ...
A consumer pricing framework for 'Cheapest Compounded Semaglutide,' 'Cheapest Compounded Semaglutide Online,' and 'Cheapest ...